National Assembly for
Wales
Health
and Social Care Committee
Follow-up
inquiry on the contribution of community pharmacy to health
services
Evidence from Hywel Dda
University Health Board – CP 2

The National
Assembly for Wales’ Health & Social Care
Committee
Inquiry on the
contribution of community pharmacy to health services
Follow-up inquiry
on -
Evidence of progress in
relation to the recommendations made in the 2012 Report, and where
progress is still required.
Recommendation
1
The Committee
recommends that the Welsh Government provides a clear national lead
for the future development of community pharmacy services to ensure
that the necessary policies and structures are in place to secure
its delivery. This should include nationally agreed
priorities for the service and a centrally driven direction for its
development.
Feedback:
1.1
The
direction in 2012 from the Chief Medical Officer to include
community pharmacies in the delivery of NHS influenza vaccinations
was a clear lead regarding the part that pharmacies can play in
contributing to the Welsh NHS. To support the influenza
vaccination service, national documentation was issued, which
allowed for some element of local implementation. The only
other service prior to this which was established nationally was
the Emergency Hormonal Contraception (EHC) enhanced
service.
1.2
National lead on agreed priorities where pharmacies could make a
contribution to the health and wellbeing of the population would be
welcomed by this University Health Board. The caveat however, is
that where nationally identified priorities are directed for
community pharmacies, consideration must also be given to the
funding necessary to implement any additional national enhanced
services.
|
|
Recommendation
2
The Committee
recommends that the Welsh Government promotes further enhanced
services with a national specification for community pharmacy,
including a national Chronic Conditions Service, and follows the
incremental model proposed for the introduction of the National
Minor Ailments Scheme to ensure robust monitoring, evaluation and
improvement of services. The Committee recommends that where
there are clearly national health conditions, the service should be
nationally specified, but that some continuing scope should be
allowed for the volume and location of such services to be
determined locally.
Feedback:
2.1
The
Influenza vaccination service is an example of central promotion of
a new enhanced service. This started in a limited way for the
2012/13 flu season (17 Pharmacies in Hywel Dda) but increased
considerably in the 2nd year of the service to 43
Pharmacies. It is anticipated that the number of Pharmacies
participating in 2014/15 flu season will further
increase.
2.2
Aware that there is a national common ailments scheme being tested
within a limited number of Health Boards. Little feedback
received on progress of common ailment scheme testing to
date.
|
|
2.3
There
is agreement that where there are national health conditions, which
result in the introduction of supporting services within Pharmacies
these should be specified nationally. However the provision
to allow for local adaptation in respect of volume and location for
any such enhanced services must be afforded to Health
Boards.
2.4
All
new national enhanced services include the requirement to input
data (to allow for monitoring, evaluation and claiming) via the
National Electronic Claim and Audit Form (NECAF). This is an
important element of any service and is welcomed by
Pharmacists. However, many existing services e.g. Just in
Case boxes continue to require paper claims, as no priority has
been given to transferring long established services onto
NECAF. Progress on this would be welcomed by Hywel Dda (and
our Community Pharmacists)
|
|
Recommendation
3
The Committee
recommends access by community pharmacists to summary patient
records where patients are registered with a community
pharmacy.
Feedback:
3.1
Not
aware of progress to date on this recommendation.
3.2
Having access to summary patient records is a vital step in
developing innovative services that can be delivered by Community
Pharmacies e.g. Independent Prescribing schemes.
|
|
Recommendation
4
The Committee
recommends that the consistent participation of community
pharmacies across Wales is secured for the next round of public
health campaigns, whether national or local. Close monitoring
of community pharmacy’s participation is required by Local
Health Boards to ensure that those failing to deliver on their
contractual obligations are called to account for their
non-compliance.

Recommendation
5
The Committee
recommends that the Welsh Government improves the communication
mechanisms it uses to inform the general public about the services
available at any individual community pharmacy. To this end,
we recommend that the Welsh Government makes it an obligation for
all community pharmacies to place a prominent notice in their
premises identifying the range of services available in that
pharmacy.

Recommendation
6
The Committee
recommends that the Welsh Government should take the opportunity
afforded by the recently announced national minor ailments scheme
to consider changes to the way in which community pharmacies are
remunerated, including a transition to capitation-based payments,
underpinned by a patient registration system.
Feedback:
6.1
This
recommendation is far reaching in its ambition, and would require
an extensive overhaul of the current remuneration system.
Progress on this is not expected in the short to medium term due to
the scale of change required.
6.2
However,
until a greater proportion of a Community Pharmacies income is
generated from means other than prescription activity there is no
incentive for Pharmacies to invest in their infrastructure and
equipment to deliver more innovative enhanced services. Staff
mix within Pharmacies and the role of accredited Pharmacy
Technicians is also an important factor in the development of
future enhanced services.
|
|
Recommendation
7
The Committee
recommends that the Welsh Government and Local Health Boards
prioritise taking proactive action to address issues of cooperation
and joint working between community pharmacist and GPs, both in
rural and urban areas.
